Pricing Log in Create free account

Axsome Therapeutics, Inc. (AXSM) vs Belite Bio, Inc. Sponsored ADR (BLTE)

Axsome Therapeutics, Inc. and Belite Bio, Inc. Sponsored ADR are both Biotechnology companies. Axsome Therapeutics, Inc. is the larger, with a market value of $6.8B against $5.8B — 1.2× the size. Belite Bio, Inc. Sponsored ADR has the higher net margin (0.00% vs −18.2%) and the lower return on invested capital (−9.55% vs 0.00%). Across the 13 metrics below, Belite Bio, Inc. Sponsored ADR leads on 9 and Axsome Therapeutics, Inc. on 4.

Valuation

Metric AXSM BLTE Biotechnology median
P/E n/m n/m 10.26
P/S 7.83 n/m 9.18
P/B 64.25 7.48 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 7.61 n/m 8.98
Earnings yield (2.37%) (1.90%) (34.89%)
Free cash flow yield (1.22%) (1.16%) (24.52%)

Profitability

Metric AXSM BLTE Biotechnology median
Gross margin 93.25% — 65.16%
Operating margin (17.45%) 0.00% 0.00%
Net margin (18.18%) 0.00% 0.00%
Free cash flow margin (9.55%) 0.00% 0.00%
Return on equity (175.59%) 0.00% (50.12%)
Return on assets (21.03%) (21.60%) (45.60%)
Return on invested capital 0.00% (9.55%) 0.00%

Growth

Metric AXSM BLTE Biotechnology median
Revenue growth (TTM) 54.16% — 6.26%
EPS growth (last fiscal year) 38.56% (95.76%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AXSM BLTE Biotechnology median
Debt to equity 1.21 0.00 0.00
Current ratio 1.42 33.56 4.89
Net debt to EBITDA 1.29 5.88 1.01

Dividend

Metric AXSM BLTE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AXSM BLTE Biotechnology median
Market cap 6.83b 5.77b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack